论文检索
期刊
全部知识仓储预印本开放期刊机构
高级检索

不同剂量右美托咪定在喉返神经监测甲状腺手术中的应用效果OACSTPCD

Application effect of different doses of dexmedetomidine in thyroid surgery under recurrent laryngeal nerve monitoring

中文摘要英文摘要

目的 观察不同剂量右美托咪定在喉返神经监测甲状腺手术中的应用效果.方法 选取2021年10月至2023年6月该院行全身麻醉下甲状腺手术且术中采用喉返神经监测的患者60例为研究对象,随机数字表法分为对照组(A组)、低剂量组(B组)、高剂量组(C组).B组、C组在麻醉诱导前分别使用右美托咪定0.3 μg/kg、0.6 μg/kg微泵泵注作为负荷剂量,微泵泵注0.3 μg·kg-1·h-1、0.6 μg·kg-1·h-1进行麻醉维持,A组采用等量的生理盐水.各组其他麻醉管理方式相同.记录入室后(T0)、麻醉诱导前(T1)、麻醉诱导后(T2)、插管后1 min(T3)、手术划皮即刻(T4)、分离甲状腺时(T5)、拔管后1 min(T6)的平均动脉压(MAP)、心率,以及不良反应发生率、呛咳反应评分、停药后拔管时间、丙泊酚和瑞芬太尼用量.结果 呛咳反应评分、停药后拔管时间、丙泊酚用量均表现为C组<B组<A组(P<0.05),C组、B组瑞芬太尼用量少于A组(P<0.05).T1时点,C组MAP低于A组、B组(P<0.05),但A组与B组比较差异无统计学意义(P>0.05);T2~T6时点,B组、C组MAP均低于A组,但B组与C组比较差异无统计学意义(P>0.05).T1~T6时点,B组、C组心率均低于A组(P<0.05);T1、T2、T4、T5、T6时点,C组心率低于B组(P<0.05).各组术中均未出现心动过缓,术中喉返神经监测过程顺利未出现干扰,各组不良反应发生率比较差异无统计学意义(P>0.05).结论 喉返神经监测甲状腺手术患者应用0.6 μg/kg右美托咪定的血流动力学更平稳,可以降低麻醉药物用量,减少呛咳反应的发生,缩短术后拔管时间,且不增加术后不良反应发生率.

Objective To observe the application effect of different doses of dexmedetomidine in thyroid surgery under recurrent laryngeal nerve monitoring.Methods A total of 60 patients with thyroid surgery un-der general anesthesia,moreover adopting recurrent laryngeal nerve monitoring during the operation,in this hospital from October 2021 to June 2023 were selected as the study subjects and divided into the control group(group A),low dose group(group B)and high dose group(group C)by the random number table method.The group B and group C respectively used dexmedetomidine 0.3 μg/kg and 0.6 μg/kg as a loading dose be-fore anesthesia induction,0.3 μg·kg-1·h-1 and 0.6 μg·kg-1·h-1 were respectively injected by mi-cropump for anesthesia maintenance,while the group A adopted the same amount of normal saline.The other anesthesia management methods were the same in the three groups.The mean arterial pressure(MAP)and heart rate after entering the room(T0),before anesthesia induction(T1),after anesthesia intubation(T2),at 1 min after anesthesia intubation(T3),immediately after surgical incision(T4),isolation of the thyroid gland(T5)and at 1 min after extubation(T6),incidence rate of adverse reactions,choking reaction score,extubation time after stopping medication and dosage of propofol and remifentanil were recorded.Results The choking reaction score,extubation time after stopping medication and propofol dosage were manifested as the group C<group B<group A(P<0.05).The remifentanil dosage in group C and group B was less than that in group A(P<0.05).MAP at T1 in the group C was lower than that in the group A and group B(P<0.05),but there was no statistical difference between the group A and group B(P>0.05).MAP at T2-T6 in the group B and group C was lower than that in the group A(P<0.05),but the difference between the group B and group C had no statistical significance(P>0.05).The heart rate at T1-T6 in the group B and group C was lower than that in the group A(P<0.05).The heart rate at T1,T2,T4,T5 and T6 in the group C was lower than that in the group B(P<0.05).Bradycardia during operation did not occur in various groups.The intraoperative recurrent laryngeal nerve monitoring process was smooth without appearing interference.The incidence rate of adverse reactions had no statistical difference in various groups(P>0.05).Conclusion He-modynamics by using 0.6 μg/kg dexmedetomidine in the patients with thyroid operation under recurrent la-ryngeal nerve monitoring is more smooth and steady,which could reduce the use amounts of anesthetic drugs,decrease the occurrence of choking reaction,shorten the operation extubation time after operation,moreover does not increase the incidence rate of postoperative adverse reactions.

莽文博;吕磊;周龙媛;袁园;陈高翔

宁波市医疗中心李惠利医院麻醉科,浙江宁波 315000宁波市医疗中心李惠利医院重症医学科,浙江宁波 315000宁波市医疗中心李惠利医院甲乳外科,浙江宁波 315000

临床医学

喉返神经监测;右美托咪定;甲状腺手术;剂量

recurrent laryngeal nerve monitoring;dexmedetomidine;thyroid surgery;dose

《重庆医学》 2024 (013)

1947-1951 / 5

浙江省基础公益研究计划项目(LGF20H70001).

10.3969/j.issn.1671-8348.2024.13.005

评论

下载量:0
点击量:0